Neuroinflammation in Neurodegenerative Diseases: New Insights and Therapeutic Targets
Neuroinflammation has emerged as a central pathogenic driver in a wide range of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Chronic glial activation and dysregulated immune signaling were once considered merely secondary consequences of neuronal loss, but are now recognized as...
0 Shares
318 Views
0 Reviews